LabCorp Enhances HCV Testing Services with the Launch of IL-28B Test

Assay is Commercially Available for Patient Testing and Clinical Trials BURLINGTON, N.C., Aug 23, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) announced today the nationwide availability of a genetic test to detect the presence of a single

LabCorp Establishes Global Clinical Trials Collaboration with Clearstone Central Labs

BURLINGTON, N.C., Aug 12, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing

LabCorp Announces $250 Million Stock Repurchase Program

BURLINGTON, N.C., Aug 09, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an additional aggregate of $250 million of its Common Stock

Laboratory Corporation of America(R) Holdings Announces 2010 Second Quarter Results

Strong Revenue Growth Drives Increase of 12.3% in EPS and 18.5% in Operating Cash Flow BURLINGTON, N.C., Jul 22, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced results for the quarter ended June 30, 2010.

Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Jul 01, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and

LabCorp is Scheduled to Present at the William Blair & Company 30th Annual Growth Stock Conference

BURLINGTON, N.C., Jun 09, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the William Blair & Company 30th Annual Growth Stock Conference in Chicago, IL.

LabCorp(R) Scheduled to Webcast Its Annual Meeting of Stockholders

BURLINGTON, N.C., May 10, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Annual Meeting of Stockholders will be webcast live beginning May 12, 2010 at 9:00 a.m. Eastern Time via the Company Web site at www.labcorp.com.

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2010 Health Care Conference

BURLINGTON, N.C., May 06, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch Health Care Conference in New York, NY.

Laboratory Corporation of America(R) Holdings Announces 2010 First Quarter Results

3.3% Revenue Growth, Despite Severe Weather, Drives Adjusted EPS of $1.30 BURLINGTON, N.C., Apr 21, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter ended March 31, 2010.

Duke, LabCorp Combine Forces to Create The Biomarker Factory

DURHAM, N.C. & BURLINGTON, N.C., Apr 20, 2010 (BUSINESS WIRE) --Duke University Medical Center and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today the formation of a joint venture to commercialize new biomarkers. The new entity is designed to speed the